The future is now ❤️🔥
My ode to Jaromir Jagr, who appears to be retiring. He’s no doubt a top 10 all-time player. But when it comes to being cool, he has no competition.
My column:
nytimes.com/athletic/7788493…
6
The future is now ❤️🔥
Daridorexant 🧠
Children who own a smartphone face significantly higher odds of experiencing depression, obesity, and sleep deprivation, according to an extensive analysis of more than 10,000 American youths. Led by Ran Barzilay at Children's Hospital of Philadelphia alongside collaborators at the University of California, Berkeley, and Columbia University, the research team evaluated data from 10,588 participants enrolled in the Adolescent Brain Cognitive Development Study.
Published in the journal Pediatrics, the findings reveal striking health disparities tied to early device ownership. Compared with 12-year-olds who did not own a smartphone, peers who had one exhibited 31% higher odds of depression, 40% higher odds of obesity, and 62% higher odds of insufficient sleep. Furthermore, the younger a child was when they received their first device, the greater their risk for obesity and poor sleep became. Among adolescents who remained phone-free at age 12, those who acquired a smartphone over the following year faced 57% higher odds of clinical-level psychopathology and 50% higher odds of insufficient sleep by age 13 compared to peers who stayed without a device.
Because the median age for acquiring a first smartphone in the cohort was just 11 years old, many families confront this milestone while their children are still in elementary school. Barzilay advises caregivers to approach the choice as a major health decision, emphasizing that handing a child a smartphone carries meaningful implications for their well-being. At the same time, he notes that smartphones are neither inherently harmful nor universally beneficial, recognizing that they also help young people stay connected, access educational resources, and remain safe.
Crucially, the observational study demonstrates an association rather than proving that smartphones directly cause these adverse outcomes, even after investigators adjusted for household income, demographics, and parenting factors. Additionally, the analysis did not examine how children were specifically using their devices, a question the researchers intend to explore next alongside investigating the health impacts of receiving a smartphone before age 10.
[Barzilay, R., Pimentel, S. D., Tran, K. T., Visoki, E., Pagliaccio, D., & Auerbach, R. P. (2026). Smartphone ownership, age of smartphone acquisition, and health outcomes in early adolescence. Pediatrics, 157(1), e2025072941. DOI: 10.1542/peds.2025-072941]
5
The future is now ❤️🔥
Nanopore direct RNA sequencing reveals the 2'-O-methylation landscape and SNORD88B-guided FN1 modification in hepatocellular carcinoma. SNORD88B was significantly upregulated in liver cancer stem cells, its guide sequence displayed perfect base-pairing complementarity with the Nm-modified region of fibronectin 1 (FN1) mRNA. Furthermore, single-cell RNA sequencing analysis revealed that FN1 was specifically expressed in hepatocellular carcinoma tumor cell clusters. doi.org/10.1016/j.ncrna.2026…
20
The future is now ❤️🔥
Hockey is about to lose something we may NEVER see again. 💔🏒
Jaromír Jágr was playing professional hockey before some of today’s NHL stars were even born.
Think about that.
He watched entire generations come and go. Teammates became coaches. Rivals became Hall of Famers. Players who grew up idolizing him eventually retired themselves.
And through it all, Jágr just kept playing.
Now, at 54 years old, the legendary No. 68 is finally admitting that his heart may no longer be in it.
He says he has no problem with never playing another game.
That’s the part that hits hardest.
After more than three decades of professional hockey, 1,921 NHL points, and two Stanley Cups, the man who seemingly couldn’t walk away from the game has finally found peace with the possibility of leaving it behind.
Nothing is official yet, but this feels different.
We all knew this day would eventually come. We just never wanted to believe it.
One last standing ovation for Jaromír Jágr. 👏❤️
If you grew up watching No. 68, you know how special this man was.
23
The future is now ❤️🔥
Jaromir Jagr is ready to call it a career after 38 professional seasons 🥹
The 54-year-old says playing no longer feels right, and he’s at peace with never suiting up again.
He hasn’t made an official retirement announcement. (via @DenikSport)
26
The future is now ❤️🔥
edhub.ama-assn.org/jn-learni…
19
The future is now ❤️🔥
"Lilly made 64% of its 2025 sales from medicines approved in the last five years. Sanofi is second, at 14%. Amgen is third, at 12%. Everyone else in the top 20 is in single figures, and Gilead and Novo Nordisk are at zero.
The revenue age tells the same story, even if it does it more quietly. Lilly’s is 6.6 years. For most of the group, it sits between eleven and thirteen."
@DaveARicks
The Aftermath Index
asymmetriclearning.substack.…
36
The future is now ❤️🔥
Romania is building a genomic reference to better represent its population's diversity. The Romanian Genome Project, part of Genomes of Europe & ELRIN, aims to establish high-quality genomic reference datasets for Romania, alongside rare disease research
lnkd.in/gZNJcgkN
21
The future is now ❤️🔥
Daridorexant 🧠 🫀 🪄 has tremendous potential IMHO ⚡
news.mit.edu/2026/waste-clea…
20
The future is now ❤️🔥
Lifelong 🤪
A man who discontinued his GLP-1 medication after shedding 100 pounds was hospitalized shortly afterward in the midst of a full-blown manic episode, and clinicians warn this is not an isolated incident.
Reporting their findings in The Primary Care Companion for CNS Disorders, physicians documented the clinical histories of two adult men who had been prescribed tirzepatide, the dual-agonist drug marketed as Mounjaro for type 2 diabetes and Zepbound for chronic weight management. In the first case, a 61-year-old man stopped taking the medication in August 2025 due to persistent nausea. Roughly two months later, he required hospitalization after developing severe paranoia, auditory and visual hallucinations, and Cotard delusion, a rare neuropsychiatric condition in which a person believes they are dead or no longer exist.
In the second case, a 52-year-old man abruptly discontinued tirzepatide in September 2025 following a 100-pound weight loss. Just one month later, he was admitted to the hospital exhibiting acute mania, characterized by rapid and incoherent speech, severe irritability, impulsivity, and grandiose beliefs.
Both patients required antipsychotic pharmacotherapy to stabilize their symptoms, and the first man was subsequently readmitted for severe depression with catatonic features, ultimately requiring electroconvulsive therapy. The authors describe these abrupt mood and psychotic episodes as an underrecognized clinical phenomenon, urging healthcare providers to closely monitor patients when discontinuing GLP-1 receptor agonists, which are now utilized by tens of millions of people worldwide.
While these severe psychiatric reactions appear to be uncommon, the cases highlight the importance of consulting a prescribing physician before modifying or stopping treatment rather than discontinuing the medication abruptly on your own, while giving researchers a critical neurobiological question to investigate.
[The Primary Care Companion for CNS Disorders. (2026). Mood and psychotic symptoms after rapid discontinuation of a GLP-1 agonist. DOI: 10.4088/PCC.26cr04215]
33







































